Literature DB >> 18781088

Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression.

Shinsuke Kito1, Kenichi Fujita, Yoshihiko Koga.   

Abstract

Several studies have proved that low-frequency transcranial magnetic stimulation (TMS) of the right dorsolateral prefrontal cortex (DLPFC) showed an antidepressant effect, although its mechanism is still not completely elucidated. The aim of the present study was to clarify the alteration in neuroanatomical function elicited by low-frequency TMS of the right DLPFC in treatment-resistant depression and to detect the difference between responders and nonresponders to TMS. Single-photon emission computed tomography with (99m)Tc-ethyl cysteinate dimer was performed in 14 right-handed male patients with treatment-resistant unipolar depression before and after low-frequency TMS of the right DLPFC. Five 60-second 1-Hz trains were applied and 12 treatment sessions were administered within a 3-week period (total pulses, 3,600). The Hamilton Rating Scale for Depression was administered and the regional cerebral blood flow (rCBF) was analyzed using statistical parametric mapping (SPM2). After TMS treatment in 14 patients, the score on the Hamilton Rating Scale for Depression decreased significantly, and considerable decreases in rCBF were seen in the bilateral prefrontal, orbitofrontal, anterior insula, right subgenual cingulate, and left parietal cortex, but no significant increase in rCBF occurred. Additionally, as compared with 8 nonresponders, 6 responders showed significant increases in rCBF at baseline in the left hemisphere including the prefrontal and limbic-paralimbic regions. These results suggest that the antidepressant effect of low-frequency TMS of the right DLPFC is associated with a decrease in rCBF in the limbic-paralimbic regions via the ipsilateral subgenual cingulate, and increased rCBF at baseline in the left hemisphere may be involved in the response to low-frequency TMS treatment. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781088     DOI: 10.1159/000154477

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  26 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

2.  Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression.

Authors:  Raphaelle Richieri; Laurent Boyer; Jean Farisse; Cecile Colavolpe; Olivier Mundler; Christophe Lancon; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-07       Impact factor: 9.236

3.  Identification of reproducible individualized targets for treatment of depression with TMS based on intrinsic connectivity.

Authors:  Michael D Fox; Hesheng Liu; Alvaro Pascual-Leone
Journal:  Neuroimage       Date:  2012-11-07       Impact factor: 6.556

4.  Loss of white matter integrity in major depressive disorder: evidence using tract-based spatial statistical analysis of diffusion tensor imaging.

Authors:  Mayuresh S Korgaonkar; Stuart M Grieve; Stephen H Koslow; John D E Gabrieli; Evian Gordon; Leanne M Williams
Journal:  Hum Brain Mapp       Date:  2010-12-17       Impact factor: 5.038

5.  Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression.

Authors:  Stephan F Taylor; S Shaun Ho; Tessa Abagis; Mike Angstadt; Daniel F Maixner; Robert C Welsh; Luis Hernandez-Garcia
Journal:  J Affect Disord       Date:  2018-02-21       Impact factor: 4.839

6.  Identification of Clinical Features and Biomarkers that may inform a Personalized Approach to rTMS for Depression.

Authors:  Sarah L Garnaat; Andrew M Fukuda; Shiwen Yuan; Linda L Carpenter
Journal:  Pers Med Psychiatry       Date:  2019-10-18

7.  Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.

Authors:  Michael D Fox; Randy L Buckner; Matthew P White; Michael D Greicius; Alvaro Pascual-Leone
Journal:  Biol Psychiatry       Date:  2012-06-01       Impact factor: 13.382

Review 8.  Neuroimaging Mechanisms of Therapeutic Transcranial Magnetic Stimulation for Major Depressive Disorder.

Authors:  Noah S Philip; Jennifer Barredo; Emily Aiken; Linda L Carpenter
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-11

9.  Default mode network mechanisms of transcranial magnetic stimulation in depression.

Authors:  Conor Liston; Ashley C Chen; Benjamin D Zebley; Andrew T Drysdale; Rebecca Gordon; Bruce Leuchter; Henning U Voss; B J Casey; Amit Etkin; Marc J Dubin
Journal:  Biol Psychiatry       Date:  2014-02-05       Impact factor: 13.382

Review 10.  Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.

Authors:  Thiago M Fidalgo; J Leon Morales-Quezada; Guilherme S C Muzy; Noelle M Chiavetta; Mariana E Mendonca; Marcus V B Santana; Oscar F Goncalves; Andre R Brunoni; Felipe Fregni
Journal:  J ECT       Date:  2014-03       Impact factor: 3.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.